BiotechTube
Home/Syros Pharmaceuticals/Conley Chee
CC

Conley Chee

Chief Executive Officer

Syros Pharmaceuticals

Therapeutic Areas

Oncology

Syros Pharmaceuticals Pipeline

DrugIndicationPhase
Tamibarotene (SY-1425)RARA-positive Higher-Risk MDSPhase 3
SY-2101Acute Promyelocytic Leukemia (APL)Phase 3
SY-5609Solid TumorsPhase 1/2
SY-5007RET-altered Solid TumorsPreclinical

Leadership Team at Syros Pharmaceuticals

DA
David A. Roth
Chief Medical Officer
JH
Jason Haas
Chief Financial Officer
ER
Eric R. Olson
Chief Scientific Officer, Co-founder
MK
Marcin Kortylewski
Board Member
KA
Keith A. Katkin
Board Member
NS
Nancy Simonian
Former Chief Executive Officer
View full Syros Pharmaceuticals profile